Fred Alger Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-558,570
Closed -$17M 431
2024
Q1
$17M Sell
558,570
-595,488
-52% -$19.9M 0.08% 160
2023
Q4
$41.2M Sell
1,154,058
-281,756
-20% -$10.5M 0.22% 92
2023
Q3
$62.9M Sell
1,435,814
-29,564
-2% -$1.44M 0.36% 74
2023
Q2
$72.3M Sell
1,465,378
-45,926
-3% -$2.12M 0.37% 79
2023
Q1
$62.6M Sell
1,511,304
-244,094
-14% -$10.1M 0.34% 97
2022
Q4
$77.9M Sell
1,755,398
-572,077
-25% -$23.9M 0.42% 74
2022
Q3
$91M Sell
2,327,475
-188,020
-7% -$8.6M 0.46% 59
2022
Q2
$103M Sell
2,515,495
-243,860
-9% -$11.6M 0.48% 60
2022
Q1
$181M Sell
2,759,355
-481,492
-15% -$31.2M 0.58% 42
2021
Q4
$225M Sell
3,240,847
-113,839
-3% -$8.27M 0.56% 52
2021
Q3
$233M Buy
3,354,686
+12,344
+0.4% +$950K 0.56% 63
2021
Q2
$265M Buy
3,342,342
+148,925
+5% +$10.8M 0.63% 43
2021
Q1
$209M Buy
3,193,417
+332,895
+12% +$20.5M 0.55% 50
2020
Q4
$159M Buy
2,860,522
+127,141
+5% +$5.5M 0.41% 79
2020
Q3
$109M Buy
2,733,381
+429,852
+19% +$18.2M 0.32% 93
2020
Q2
$104M Buy
2,303,529
+1,040,121
+82% +$45.3M 0.34% 81
2020
Q1
$42.4M Buy
+1,263,408
New +$45.4M 0.19% 119

Other funds holding ATRC

Fred Alger Management's ATRC Position: Q2 2024 in Review

Fred Alger Management sold out of AtriCure (ATRC) in Q2 2024, closing a stake of 558,570 shares — an estimated $17M sold.

Fred Alger Management first reported a position in ATRC in Q1 2020 and held it in 17 quarters. The position peaked at $265M in Q2 2021. 197 funds tracked by Wall St. Rank hold ATRC as of Q2 2024.

  • Fred Alger Management reported no remaining AtriCure position as of Q2 2024 after selling out during the quarter.
  • Fred Alger Management sold 558,570 AtriCure shares in Q2 2024, an estimated $17M.
  • Fred Alger Management first reported a position in AtriCure in Q1 2020 and held it in 17 quarters.
  • Fred Alger Management's AtriCure position peaked at $265M in Q2 2021.
  • 197 funds tracked by Wall St. Rank held AtriCure as of Q2 2024.

Based on Fred Alger Management's 13F filing for Q2 2024, filed 14 Aug 2024.